Financials

Discussions Technicals Seasonals

338840 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Y-Biologics, Inc. operates as a biopharmaceutical company, which engages in the research and development of antibody therapeutics. The firm’s products include Ymax ABL, a human antibody library and ALiCE, a novel format for bispecific T-cell engager antibodies. The company was founded on December 31, 2007 and is headquartered in Daejeon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

338840 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company